Related Experiment Video
Updated: May 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Poor uptake of community based sexually transmissible infection testing at an inner city needle and syringe program
Lynne Martin1, Sione Crawford, Vickie Knight
1Sydney Sexual Health Centre, Sydney Hospital, GPO Box 1614, Sydney, NSW 2001, Australia.
Abstract:
Sydney Sexual Health Centre (SSHC) and the NSW Users and AIDS Association (NUAA), the NSW peer-based drug user organisation, pilot tested an outreach sexually transmissible infection (STI) testing station using self-collected urine and swabs in NUAA's needle and syringe program (NSP) space. The model was based on SSHC's established Xpress clinic. A needs assessment among NUAA clients was undertaken prior to commencement in order to ascertain potential uptake. A computer-assisted self interview was developed with data securely transferred to SSHC daily. During the 6 months from January to July 2011, almost 3000 occasions of service were recorded in the NSP from an estimated 375 clients. Four clients took advantage of NUAA Xpress during this time. Despite initial client interest, promotional efforts and the success of this methodology elsewhere, this outreach model did not have a successful uptake and was discontinued. This project provides value in considering the methodology and implementation of future outreach STI testing projects for people who inject drugs.
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urine Studies II: Urine Culture and Sensitivity Test
